|
시장보고서
상품코드
2052856
관절내 점성보충 시장 : 투여량별, 관절염 종류별, 최종사용자별, 지역별Viscosupplementation Market, By Dosage, By Arthritis Type, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
관절내 점성보충 시장은 2026년에 44억 9,000만 달러로 추정되며, 2033년까지 78억 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 8.2%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 44억 9,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.20% | 2033년 시장 규모 예측: | 78억 달러 |
관절내 점성보충은 슬관절염으로 인한 무릎 통증을 관리하기 위해 사용되는 정형외과적 치료법입니다. 히알루론산(히알루론산이라고도 함)을 슬관절에 주입하는 것입니다. 히알루론산은 관절 내에서 윤활제 및 충격 흡수제 역할을 합니다. 골관절염으로 인해 감소된 관절 내 히알루론산을 보충합니다. 이를 통해 골관절염에 걸린 무릎의 활액의 점성을 보충하여 통증 감소와 운동성 개선에 도움을 줍니다. 관절내 점성보충은 무릎 골관절염의 증상을 장기간 완화시켜주는 비수술적 치료법입니다.
시장 역학
세계 관절내 점성보충 시장은 골관절염과 그에 따른 관절통에 취약한 고령 인구의 증가에 의해 주도되고 있습니다. 현재 전 세계적으로 3억 3,000만 명 이상이 골관절염을 앓고 있는 것으로 추산됩니다. 이 숫자는 향후 몇 년 동안 크게 증가할 것으로 예상됩니다. 또한, 첨단 비침습적 치료법에 대한 인식 개선과 관절내치환술에 대한 유리한 보험급여 정책이 시장을 견인하고 있습니다. 그러나 건강기능식품과 같은 대체 치료법의 선호와 히알루론산 주사의 통증 완화 효과 및 지속 기간의 한계는 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 환자별로 최적화된 히알루론산 제제를 개발하기 위한 3D 프린팅과 로봇 기술의 통합은 이 시장에서 유망한 비즈니스 기회를 제공합니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 관절내 점성보충 시장의 주요 업체를 프로파일링합니다 : 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 관절 내 치환술 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 관절내 점성보충 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 관절내 점성보충 시장 : 투여량별, 2021-2033년
제5장 세계의 관절내 점성보충 시장 : 관절염 종류별, 2021-2033년
제6장 세계의 관절내 점성보충 시장 : 최종사용자별, 2021-2033년
제7장 세계의 관절내 점성보충 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 견해
제10장 참고문헌 및 조사 방법
KSM 26.06.17Viscosupplementation Market is estimated to be valued at USD 4.49 Bn in 2026 and is expected to reach USD 7.80 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.49 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.20% | 2033 Value Projection: | USD 7.80 Bn |
Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the joint that diminish with osteoarthritis. This helps reduce pain and improve mobility by supplementing the viscous nature of the synovial fluid in knees affected by osteoarthritis. Viscosupplementation therapy is a non-surgical treatment option that provides relief from knee osteoarthritis symptoms for extended periods of time.
Market Dynamics
The global viscosupplementation market is driven by the rising geriatric population which is more prone to develop osteoarthritis and the associated joint pains. As per estimates, over 330 million people currently suffer from osteoarthritis globally. This is projected to increase substantially in the coming years. Moreover, growing awareness about advanced non-invasive treatment alternatives and favorable reimbursement policies for viscosupplementation procedures are boosting the market. However, the market growth can be restrained by the preference for alternative treatment methods like dietary supplements and limitations in the efficacy and duration of pain relief provided by hyaluronic acid injections. The integration of 3D printing and robotic technologies to develop patient-specific hyaluronic acid formulations provides lucrative opportunities in this market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global viscosupplementation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Aptissen, Wellchem Pharmaceuticals Pte Ltd., Juniper Biologics, and Ono Pharmaceutical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global viscosupplementation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viscosupplementation market.
Market Segmentation
- Dosage Insights (Revenue, USD Bn, 2021 - 2033)
- Single Injection
- Three Injection
- Five Injection
- Arthritis Type Insights (Revenue, USD Bn, 2021 - 2033)
- Osteoarthritis
- Rheumatoid Arthritis
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Anika Therapeutics Inc.
- Seikagaku Corporation
- Ferring Pharmaceuticals
- Bioventus
- Fidia Farmaceutici S.P.A.
- Mylan N.V.
- Sanofi S.A.
- OrthogenRx
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- F. Hoffmann-La Roche AG
- Zimmer Biomet
- Aptissen
- Wellchem Pharmaceuticals Pte Ltd.
- Juniper Biologics
- Ono Pharmaceutical Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage
- Market Snapshot, By Arthritis Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
4. Global Viscosupplementation Market, By Dosage, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Single Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Three Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Five Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Viscosupplementation Market, By Arthritis Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Viscosupplementation Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Viscosupplementation Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Anika Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Seikagaku Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ferring Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bioventus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fidia Farmaceutici S.P.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ORTHOGENRX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aptissen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Wellchem Pharmaceuticals Pte Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Juniper Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ono Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
